Abstract:Indoor environment is an important repository of microbiome. Environmental microbiome can influence immune protection through changing the commensal flora of the respiratory tract. The interaction between environment airborne microbiome and human microbiome contributes to human microbial diversity, provides immunomodulatory effects, and thus reduces the risk of respiratory diseases. Lack of immune modulation acquired through microbial exposure may lead to risk of chronic respiratory diseases. Clinical parameters, such as susceptibility, progression, and severity of respiratory disease, are associated with microbial changes. Chronic obstructive pulmonary disease, cystic fibrosis, asthma, and lung cancers are associated with airway microbial dysbiosis. The changes of microbiome during the disease period are mainly characterized by a decrease in overall bacterial diversity, a decrease in the number of commensal bacteria, and an increase in the number of potential pathogenic bacteria. Based on the perception that pathogenic or conditional pathogenic microbiome is responsible for the infection and transmission of respiratory and non-respiratory diseases, public health policies have long favored keeping indoors at lower concentrations of microbiome or even absolutely sterile. However, in the past decade, an in-depth understanding of the microbiology of the environment and human health has shifted researchers' view of indoor microbiome from a purely pathogenic and infectious negative role to a potentially protective, preventive positive role. Facing with the dual health effects of indoor airborne microbiome, the ideal control strategy should be to increase the microbial diversity and the proportion of beneficial microbiome, while reducing the concentration of pathogenic microbiome for regions, seasons, and sensitive populations. However, there is still no paradigm shift in built environment microbiology due to technical bottlenecks that prevent researchers from establishing a causal relationship between indoor microbiome and health effects. Currently, the types and properties of indoor airborne microbiome are yet to be fully screened and understood. The characteristics of indoor microbiome when they exert health effects are yet to quantify, including microbial metabolization and reproduction in the respiratory tract, corresponding protective effects, and dose-response effects and individual variation in health effects. The answer to the question "What is a healthy indoor air microbial environment", that is, the characterization of indoor airborne microbiome based on respiratory health effects, is hindered by respiratory microbial sampling, in-depth analysis of microbial data, and the accuracy of in vitro experiments. Subsequent research needs to focus on the development of the following techniques: Microbial sampling tools with low invasiveness, high efficiency and low cost; statistical tools with complex source identification, interference factor quantification and causal relationship judgment functions; and experimental tools capable of simulating real, complex respiratory environments and revealing molecular mechanisms of action in vivo. "What is a healthy indoor air microbial environment" will gradually become clear as these questions are resolved. A clear and quantitative mechanism will serve as a scientific basis to guide the improvement of indoor microbial control standards and the rational use of practical interventions.

Determining the toxicological effects of indoor air pollution on both a healthy and an inflammatory-comprised model of the alveolar epithelial barrier in vitro

Assessing susceptibility for polycyclic aromatic hydrocarbon toxicity in an in vitro 3D respiratory model for asthma

55 Investigating the co-Exposure of Micro(nano)Plastics and Indoor/Outdoor Particulate Matter Using an Alveolar BarrierIn Vitro Model

Research Status and Prospects of Indoor Airborne Microbiome Based on Respiratory Health Effects

Establishment of Repeated In Vitro Exposure System for Evaluating Pulmonary Toxicity of Representative Criteria Air Pollutants Using Advanced Bronchial Mucosa Models

Human airway construct model is suitable for studying transcriptome changes associated with indoor air particulate matter toxicity

Indoor Exposure to Selected Air Pollutants in the Home Environment: A Systematic Review

Air-liquid interface (ALI) model of human bronchial epithelia cells for the investigation of asthma exacerbations

Inflammatory and Oxidative Stress Responses of Healthy Adults to Changes in Personal Air Pollutant Exposure

Cell line-based in vitro models of normal and chronic bronchitis-like airway mucosa to study the toxic potential of aerosolized palladium nanoparticles

On the dose-response association of fine and ultrafine particles in an urban atmosphere: toxicological outcomes on bronchial cells at realistic doses of exposure at the Air Liquid Interface

Indoor Air Pollution and Airway Health

Inhalable particles and pulmonary host defense: in vivo and in vitro effects of ambient air and combustion particles

Environmental Perceptions, Mental Performance, and Physiological Responses of People with Respiratory Allergies Exposed to Reduced Indoor Air Quality.

Modeling indoor particulate exposures in inner-city school classrooms.

Different immune and functional effects of urban dust and diesel particulate matter inhalation in a mouse model of acute air pollution exposure

The Effects of Indoor Pollutants Exposure on Allergy and Lung Inflammation: An Activation State of Neutrophils and Eosinophils in Sputum

The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area

A method to estimate the chronic health impact of air pollutants in U.S. residences

Effects of air pollution on human health – Mechanistic evidence suggested by in vitro and in vivo modelling

The effect of indoor air filtration on biomarkers of inflammation and oxidative stress: a review and meta-analysis of randomized controlled trials